Literature DB >> 437918

Dissociation of anti-tumor immune responses in rats immunized with solubilized tumor-associated antigens from a methylcholanthrene-induced fibrosarcoma.

A Minami, Y Mizushima, N Takeichi, M Hosokawa, H Kobayashi.   

Abstract

Soluble tumor antigens were prepared from chemically-induced rat fibrosarcoma KMT-17 cells by various methods [Na-deoxycholate (DOC), 3 M-KCI extraction, and crude membrane preparations by mechanical disruption]. Soluble tumor antigens prepared by DOC extraction (DOC-STA) could be detected by a radioisotopic footpad assay (FPA) and they showed the strongest antigenic activity in KMT-17 immune rats. Anti-tumor immune responses in rats previously immunized with DOC-STA were measured by FPA, Winn assay, and transplantation resistance. Significant responses detected by the FPA and Winn assay were demonstrated in rats immunized with DOC-STA. However, rats previously immunized with DOC-STA showed a significant enhancement of tumor growth when challenged with KMT-17 cells. This enhancement was specific for the tumor line used. Normal rats which received adoptive transfer of thymus and spleen cells from rats immunized with DOC-STA produced specific enhancement of tumor growth as compared with non-treated rats. Administration of cyclophosphamide before immunization with DOC-STA abrogated the enhanced tumor growth in the host. These results suggest that immunization with soluble tumor antigens specifically enhanced tumor grwoth by the induction of immunosuppressor cells. Dissociation between the anti-tumor immunity detected by the FPA and Winn assay and the enhanced tumor growth detected by transplantation resistance in rats immunized with DOC-STA is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 437918     DOI: 10.1002/ijc.2910230314

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Purification of immunoprotective tumor antigens by preparative isotachophoresis.

Authors:  T L Saunders; B D Kahan; N R Pellis
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

2.  Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide.

Authors:  M Hosokawa; Y Sawamura; T Morikage; F Okada; Z Y Xu; K Morikawa; K Itoh; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

Review 3.  Noncytolytic extraction of cell surface antigens using butanol.

Authors:  S J LeGrue
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

4.  Development of highly immunogenic variants of a rat fibrosarcoma line during in vitro cultivation.

Authors:  K Yamashina; T Oikawa; M Kasai; M Naiki; I Chiba; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Reconstituted membranes of tumour cells (proteoliposomes) induce specific protection to murine lymphoma cells.

Authors:  J J Bergers; W Den Otter; J W De Groot; A W De Blois; H F Dullens; P A Steerenberg; D J Crommelin
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Comparison of excision versus cryosurgery of an HSV-2-induced fibrosarcoma. I. Survival, extent of metastatic disease and host immunocompetence following surgery.

Authors:  M G Wing; J R Goepel; G Jacob; R C Rees; K Rogers
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

7.  Characterisation of suppressor cells generated following cryosurgery of an HSV-2-induced fibrosarcoma.

Authors:  M G Wing; K Rogers; G Jacob; R C Rees
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

8.  In vivo detection and partial characterization of effector and suppressor cell populations in spleens of mice with large metastatic fibrosarcomas.

Authors:  L A Dent; J J Finlay-Jones
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640

9.  Isolation and properties of tumor-derived endothelial cells from rat KMT-17 fibrosarcoma.

Authors:  N Utoguchi; A Dantakean; H Makimoto; Y Wakai; Y Tsutsumi; S Nakagawa; T Mayumi
Journal:  Jpn J Cancer Res       Date:  1995-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.